Cite
HARVARD Citation
Fukasawa, T. et al. (2017). Contribution of Soluble Forms of Programmed Death 1 and Programmed Death Ligand 2 to Disease Severity and Progression in Systemic Sclerosis. Arthritis & rheumatology. 69 (9), pp. 1879-1890. [Online].